Proactive Investors - Run By Investors For Investors

Canadian medical marijuana company MPX Bioceutical uplists to OTCQX exchange

CEO W Scott Boyes said the move would improve liquidity in the company’s stock and drive shareholder value
MPX Bioceutical's Health Health for Life outlet in Arizona
The Canadian medical marijuana company has a growing presence in the US

MPX Bioceutical Corp (CSE:MPX, OTCMKTS:MPXEF) announced Wednesday that shares of the Canadian medical marijuana company have moved to the OTCQX market.

Stocks that trade on the OTCQX meet more stringent qualification criteria compared to other over-the-counter stocks that trade in the OTCQB Venture and more speculative Pink Sheets.  

“Over the past year MPX experienced significant operational changes and reached many corporate milestones, growing its Arizona footprint, acquiring cultivation, production and kitchen facilities in Nevada, opening its first cannabis dispensary in Maryland and expanding into Canada,” MPX Bioceutical CEO W Scott Boyes said in a statement.

Boyes said that upgrading to the OTCQX from the OTCQB demonstrates the cannabis grower’s commitment to “transparency, professionalism and integrity.”

“It is an important step toward improving liquidity in our stock as we continue to drive shareholder value,” said Boyes.

READ: Aurora Cannabis files to list on NYSE in search of institutional investors

The Toronto-based medical marijuana company has a growing presence in the US with plans for ten dispensaries and four production facilities in four states. It already has profitable operations in Arizona where it has three fully operational Health for Life and a fourth Holistic Center dispensary.

MPX Bioceutical has a joint venture agreement with Panaxia to develop proprietary, smokeless pharma-grade products using cannabis.

In Canada, MPX Bioceutical has acquired Canveda which has a cultivation license from Health Canada. The company has also leased a 74,343 square foot cultivation and production facility in Owen Sound, Ontario and applied to Health Canada for a cannabis production and sales license.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MPX profile View Profile

MPX Bioceutical Corp Timeline

Related Articles

Dyadic Dyadic International founder and CEO Mark Emalfarb
June 04 2019
The biotechnology platform company helps drug makers negotiate the cost curve from discovery to large-scale manufacturing of low-cost enzymes and proteins that can ultimately lower the cost of healthcare
Scientist at work
May 28 2019
CaPre, a potent form of Omega-3, has been shown to reduce triglycerides, but also lower 'bad cholesterol' levels, and raise 'good' ones
Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use